Jing Xu

Jing Xu

Auto-generated profile, based on publicly available information

Jing Xu

Division of Nephrology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2023 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
XLXiaoling Luo
Xiaoling Luo
JXJing Xu
Jing Xu
SZShoulian Zhou
Shoulian Zhou
cheng xuecheng xue
cheng xue
ZCZewei Chen
Zewei Chen
ZMZhiguo Mao
Zhiguo Mao
Background: This network meta-analysis investigated the effect of various combined regimens of sodium-glucose cotransporter-2 inhibitors (SGLT2is) and renin-angiotensin-aldosterone system inhibitors (RAASis) on the occurrence of hyperkalemia in diabetic kidney disease. Methods: The risk of hyperkalemia was compared using the random-effects model of network meta-analysis, with results expressed as odds ratios (ORs) with 95% confidence intervals (CIs). The comparative effects of all medications and their combinations with placebo were ranked using the surface under the cumulative ranking probabilities. Results: In total, 27 eligible studies involving 43,589 participants with diabetic kidney disease were included. Major findings showed that the use of mineralocorticoid receptor antagonists (MRAs) on top of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) prominently increased hyperkalemia incidence when compared with placebo (OR, 6.08; 95% CI, 2.30 to 16.08), ACEI (OR, 3.07; 95% CI, 1.14 to 8.31), ARB (OR, 2.57; 95% CI, 1.10 to 6.02), SGLT2i (OR, 9.22; 95% CI, 2.99 to 28.46), renin inhibitors+ACEI/ARB (OR, 2.23; 95% CI, 1.14 to 4.36), or SGLT2i+ACEI/ARB (OR, 4.10; 95% CI, 2.32 to 7.26). Subgroup analysis among different generations of MRA found that spironolactone had the strongest effect in combination with ACEI/ARB, even higher than the combined use of ACEI and ARB (OR, 2.89; 95% CI, 1.26 to 6.63). In addition, SGLT2i had a significantly lower incidence of hyperkalemia compared with ACEI (OR, 0.33; 95% CI, 0.12 to 0.91), ARB (OR, 0.28; 95% CI, 0.13 to 0.61), dual RAASi (ACEI combined with ARB; OR, 0.17; 95% CI, 0.06 to 0.47), or MRA or renin inhibitors combined with ACEI/ARB (OR, 0.11; 95% CI, 0.04 to 0.33; OR, 0.24; 95% CI, 0.08 to 0.76, respectively). Moreover, adding SGLT2i to the combination of MRA and ACEI/ARB, as well as the combinations of different RAASis, markedly reduced the occurrence of hyperkalemia. Conclusions: Among the therapeutic drugs with the potential risk of increasing serum potassium in patients with diabetic kidney disease, MRA added an extra risk of hyperkalemia while SGLT2i had the opposite effect and could even reverse the elevation of serum potassium caused by the combined regimen, including MRAs.

25 September 2019 in Kidney and Blood Pressure Research
Verified
Journal Article
Open access
PDF file
LHLinxi Huang
Linxi Huang
cheng xuecheng xue
cheng xue
JKJianke Kuai
Jianke Kuai
MRMengna Ruan
Mengna Ruan
BYBo Yang
Bo Yang
ZMZhiguo Mao
Zhiguo Mao
Background: The different clinical characteristics of community-acquired acute kidney injury (CA-AKI) versus hospital-acquired AKI (HA-AKI) have remained inconclusive, and thus, a meta-analysis was conducted to summarize and quantify the clinical significance distinguishing the 2 types of AKI. Methods: We identified observational studies reporting the clinical characteristics and prognosis of HA-AKI and CA-AKI. ORs and mean differences (MDs) were extracted for each outcome and the results aggregated. The primary outcome was defined as the mortality rate; renal recovery, oliguria incidence, dialysis, intensive care unit (ICU) requirement, and length of hospital stay were secondary outcomes. Results: Fifteen eligible studies involving 46,157 patients (22,791 CA-AKI patients and 23,366 HA-AKI patients) were included. Mortality was significantly lower in CA-AKI than in HA-AKI patients, with an OR of 0.43 (95% CI 0.35–0.53). The incidence of oliguria and need for ICU were also lower in CA-AKI patients (OR 0.58, 95% CI 0.38–0.88; OR 0.24, 95% CI 0.14–0.40, respectively). CA-AKI patients had a shorter hospital stay (MD –9.42, 95% CI –13.73 to –5.12). The renal recovery rate and dialysis need between CA- and HA-AKI were similar (OR 1.27, 95% CI 0.53–3.02; OR 1.05, 95% CI 0.82–1.34, respectively). Conclusions: CA-AKI showed better clinical manifestations with a lower incidence of oliguria, reduced risk of ICU treatment, and shorter hospital stay. Mortality associated with CA-AKI was lower compared with HA-AKI, indicating a better prognosis. The rate of renal recovery and need for dialysis showed no significant difference between the 2 groups.

1 August 2013 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
ZMZhiguo Mao
Zhiguo Mao
JXJing Xu
Jing Xu
FXFeng yu Xing
Feng yu Xing
DCDongping Chen
Dongping Chen
CMChanglin Mei
Changlin Mei
Kidney stones in patients with autosomal dominant polycystic kidney disease are common, regarded as the consequence of the combination of anatomic abnormality and metabolic risk factors. However, complete staghorn calculus is rare in polycystic kidney disease and predicts a gloomy prognosis of kidney. For general population, recent data showed metabolic factors were the dominant causes for staghorn calculus, but for polycystic kidney disease patients, the cause for staghorn calculus remained elusive. We report a case of complete staghorm calculus in a polycystic kidney disease patient induced by repeatedly urinary tract infections. This 37-year-old autosomal dominant polycystic kidney disease female with positive family history was admitted in this hospital for repeatedly upper urinary tract infection for 3 years. CT scan revealed the existence of a complete staghorn calculus in her right kidney, while there was no kidney stone 3 years before, and the urinary stone component analysis showed the composition of calculus was magnesium ammonium phosphate. UTI is an important complication for polycystic kidney disease and will facilitate the formation of staghorn calculi. As staghorn calculi are associated with kidney fibrosis and high long-term renal deterioration rate, prompt control of urinary tract infection in polycystic kidney disease patient will be beneficial in preventing staghorn calculus formation.

20 June 2025 in Kidney360
Verified
Journal Article
Open access
KHKai Hu
Kai Hu
LYLei Yuan
Lei Yuan
cheng xuecheng xue
cheng xue
JXJing Xu
Jing Xu
STShiyin Tian
Shiyin Tian
ZMZhiguo Mao
Zhiguo Mao
Key Points: Patients receiving kidney transplantation had better overall and physical health-related quality of life, with higher EuroQoL 5-Dimension Utility Index and Physical Component Summary scores and less daily life effect from kidney disease. Mental health-related quality of life was similar among patients receiving hemodialysis, peritoneal dialysis, and kidney transplantation. Symptoms and problems of kidney disease were strongly linked to mental component summary, explaining 15.8% of mental component summary changes. Background: Health-related quality of life has gained increasing emphasis on the long-term outcome of patients taking sustained KRT. However, the influence of KRT modalities on patients' quality of life and their comparison needs further investigation. Methods: This study included 267 patients: 101 receiving hemodialysis, 87 receiving peritoneal dialysis (PD), and 79 who received kidney transplantation (KT). Health-related quality of life of patients was evaluated by Kidney Disease Quality of Life Instrument-36 and EuroQoL 5-Dimension 3-Level scales. Inverse probability of treatment weighting was used to balance patients' demographic characteristics. Results: KT improved physical activity of patients and reduced the effect of kidney disease, as shown by higher physical component summary (KT, 43.927±8.370, versus hemodialysis, 38.101±8.567, versus PD, 37.446±8.626; P < 0.001) and effects of kidney disease (KT, 71.917±24.469, versus hemodialysis, 57.654±16.722, versus PD, 53.169±17.960; P < 0.001), but did not improve mental component summary (MCS), burden of kidney disease, and symptoms and problems of kidney disease. No differences were found between hemodialysis and PD. Patients under different KRT modalities had different symptom distribution, but had close overall score in symptom evaluation. Symptoms and problems of kidney disease had the strongest association with MCS among all dimensions ( r =0.398; 95% confidence interval, 0.274 to 0.509), explaining 15.8% variation in MCS. Conclusions: KT recipients had significantly improved overall and physical aspect quality of life, meanwhile they still had similar mental problems and multiple discomforts, such as fatigue and skin problems, just as patients receiving hemodialysis and PD. The quality of life of patients receiving hemodialysis and PD was similar. The effect of comorbidities and the underlying disease leading to ESKDs on patients' quality of life should not be neglected.

6 May 2024 in Kidney360
Verified
Journal Article
Open access
FCFangzheng Cui
Fangzheng Cui
JZJieting Zhang
Jieting Zhang
MRMengna Ruan
Mengna Ruan
YLYunhui Lu
Yunhui Lu
JWJun Wu
Jun Wu
ZMZhiguo Mao
Zhiguo Mao
Key Points: The severity of acute tubular necrosis was closely associated with renal survival. Crescent and arterial lesions are significantly associated with progression to ESKD and exerted superimposing effects together with acute tubular necrosis. Tubular atrophy/interstitial fibrosis and intracapillary lesions increase the risk of CKD stage 3–5. Background: Community-acquired AKI (CA-AKI) was more likely to be comorbid with underlying kidney histopathological lesions in addition to acute tubular necrosis (ATN). Thus, we tried to clarify the histological determinants that could influence the prognosis and recovery of patients with CA-AKI with biopsy-proven ATN. Methods: Adult patients with CA-AKI with biopsy-proven ATN who underwent renal biopsy at Shanghai Changzheng Hospital from January 1, 2010, to December 31, 2018, were included and followed up for 5 years. The impacts of histopathological lesions on short-term and long-term renal dysfunction were also analyzed. Results: Multivariate analysis revealed that ATNs, crescents, and decrease of arteriole lumens increased short-term dialysis requirements. The severity of ATN was closely associated with renal survival. According to the Kaplan–Meier analysis, the severity of ATN was significantly associated with short-term dialysis needs and long-term development of ESKD during follow-up. Crescent and decrease of arteriole lumens are significantly associated with progression to ESKD and exert synergistic effects with ATN. For patients who did not progress to dialysis, tubular atrophic/interstitial fibrosis and endocapillary lesions were more relevant to partial recovery of renal function after CA-AKI at the 3-month follow-up and increased the risk of CKD stage 3–5 at the 5-year follow-up. According to our correlation analysis, endocapillary lesions and crescents were positively correlated with ATN. Conclusions: Histopathologic lesions, apart from tubular necrosis, contributed to the detrimental short-term and long-term renal prognosis of patients with CA-AKI with ATN; concomitant histopathologic lesions exerted a combined impact on renal survival together with ATN in patients with CA-AKI.

1 January 2025 in Kidney Diseases
Verified
Journal Article
Open access
FCFangzheng Cui
Fangzheng Cui
RCRui Cheng
Rui Cheng
JXJing Xu
Jing Xu
cheng xuecheng xue
cheng xue
HYHuinan Yang
Huinan Yang
ZMZhiguo Mao
Zhiguo Mao
Introduction: The progression evaluation of autosomal dominant polycystic kidney disease (ADPKD) is critical to the treatment strategy and prognosis prediction of the disease, but the current evaluation methods are time-consuming and costly. Methods: ADPKD patients were recruited in Shanghai Changzheng Hospital from February 2023 to October 2023. Based on the Mayo imaging classification (MIC) model, patients with different disease progression rates were classified into slowly progressive (SP) group (MIC 1A, 1B) or rapidly progressive (RP) group (MIC 1C, 1D, and 1E). The Raman spectra of urine samples from ADPKD patients were obtained by Surface-enhanced Raman spectroscopy (SERS) protocol and the characteristics of urine Raman spectra from SP and RP groups were analyzed. The ADPKD progression prediction model was constructed based on principal component analysis (PCA) and support vector machine (SVM). Results: After adjusting for age, gender, and renal function, there were differences in Raman intensity of the six major Raman peaks (758/794/1,184/1,288/1,346/1,385 cm−1) between patients with SP and RP ADPKD (p < 0.05). The substances of the above Raman peaks include tryptophan, uracil, adenine, phosphodiester bond, glucose, lipids, etc. The accuracy, sensitivity, and specificity of the ADPKD progression prediction model were 82.93%, 77.55%, and 86.11%, and after leaving-one-out cross validation (LOOCV), the accuracy, sensitivity, and specificity of were 70.25%, 65.31%, and 73.61%, respectively. Conclusions: Urinary SERS detection can distinguish RP ADPKD patients from SP ones noninvasively, conveniently and quickly, with reasonable accuracy, sensitivity, and specificity. SERS combined with machine learning omics techniques might be a novel method to evaluate the progression of ADPKD.